FOUNDERS GROVE WEALTH PARTNERS, LLC

Position in NVS — Novartis AG

CIK 2046157 RICHMOND, VA

Position in NVS

as of Jun 30, 2026 · filed Jul 22, 2026 Compact

Position Value

$220,348

-$4,347 QoQ

Shares Held

1,406

-4.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#1,274

of 1,603 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

FOUNDERS GROVE WEALTH PARTNERS, LLC holds $22,439,048 across 6 Drug Manufacturers - General names. NVS ranks #6 (1.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	15,366	$18,430,442
2	JNJ	Johnson & Johnson	8,327	$2,114,808
3	ABBV	AbbVie Inc.	2,939	$739,569
4	MRK	Merck & Co., Inc.	4,961	$637,488
5	GILD	Gilead Sciences, Inc.	2,346	$296,393
6	NVS	Novartis AG This page	1,406	$220,348

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$220,348	1,406	-4.4%	Shares	Sole	2026-07-22
2026-03-31	$224,695	1,471	—	Shares	Sole	2026-04-15
No filing history on record for this holder in this stock.